Page last updated: 2024-10-29

ketamine and Leukemia, Myeloid

ketamine has been researched along with Leukemia, Myeloid in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bujok, G1
Knapik, P1
MacioĊ‚, Z1
Eilers, H1
Philip, LA1
Bickler, PE1
McKay, WR1
Schumacher, MA1

Other Studies

2 other studies available for ketamine and Leukemia, Myeloid

ArticleYear
[Abnormal reaction for anaesthetics in a critically ill child with acute myeloid leukemia--case report].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2004, Volume: 57, Issue:5-6

    Topics: Acute Disease; Anesthetics, Dissociative; Anti-Anxiety Agents; Benzodiazepines; Bone Marrow Transpla

2004
The reversal of fentanyl-induced tolerance by administration of "small-dose" ketamine.
    Anesthesia and analgesia, 2001, Volume: 93, Issue:1

    Topics: Adult; Analgesics, Opioid; Anesthetics, Dissociative; Drug Therapy, Combination; Drug Tolerance; Fem

2001